HGH is presently the only company with a legal permit signed by the South African Minister of Water and Environmental Affairs to research, export and commercialise Sceletium products including our proprietary extract Zembrin®. HGH has cultivated a naturally occurring selection of Sceletium tortuosum under carefully controlled conditions which is used to produce a high quality, standardised extract made at certified EU-GMP facilities. Our propriety standardised extract is trade marked as Zembrin®. HGH has completed full pre-clinical and clinical safety studies on Zembrin® that are not applicable to other Sceletium products or extracts. Zembrin® is still in development and no products have been released yet.  Product release is planned for Q4 2011